IP Verse

Injectable Antibiotic Formulations And Their Methods Of Use - EP2874624

The patent EP2874624 was granted to Bayer on Oct 2, 2019. The application was originally filed on Jul 16, 2013 under application number EP13819728A. The patent is currently recorded with a legal status of "Opposition Rejected".

EP2874624

BAYER
Application Number
EP13819728A
Filing Date
Jul 16, 2013
Status
Opposition Rejected
Jul 22, 2022
Grant Date
Oct 2, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

OMNIPHARM DEVELOPMENTSMay 21, 2020CARPMAELS & RANSFORDADMISSIBLE
EUROVET ANIMAL HEALTHMay 20, 2020ALGEMEEN OCTROOI EN MERKENBUREAUADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTCN1517090
INTERNATIONAL-SEARCH-REPORTUS4446144
OPPOSITIONCA1237672
OPPOSITIONCN101822637
OPPOSITIONCN1517090
OPPOSITIONEP0941095
OPPOSITIONGB2087236
OPPOSITIONUS2004022815
OPPOSITIONUS2011223208
OPPOSITIONUS4446144
OPPOSITIONUS4594246
OPPOSITIONUS6911441
OPPOSITIONWO2004014339
OPPOSITIONWO2011128783
OTHERCA1237672
OTHERCN101822637
OTHERCN1517090
SEARCHGB2087236
SEARCHUS4594246

Non-Patent Literature (NPL) Citations (43) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- JAIN R ET AL, "A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, NEW YORK, NY, US, vol. 50, no. 5, doi:10.1016/J.JPBA.2009.06.046, ISSN 0731-7085, (20091205), pages 841 - 846, (20090703), XP026640020
OPPOSITION- Anonymous, "Cobactan 2.5% w/v Suspension for Injection", Summary of Product Characteristics, (20120312), pages 1 - 5, XP093011910-
OPPOSITION- Anonymous, "Cobactan 4.5% w/v powder and solvent for solution for injection for horse and cattle", Summary of Product Characteristics, (20120517), pages 1 - 8, XP093011909-
OPPOSITION- Anonymous, "MORE SOLUTIONS TO STICKY PROBLEMS - A GUIDE TO GETTING MORE FROM YOUR BROOKFIELD YISCOMETER", Brookfield Brochure, (19971201), pages 2pp, 1 - 26, XP093011760-
OPPOSITION- Anonymous, "Penethaject®", (20180116), URL: https://www.bayer.co.nz/products/product-details.php?id=941, XP093011773-
OPPOSITION- Bayer, "Penethaject ", Safety Data Sheet, (20130601), pages 1 - 7, XP093011775-
OPPOSITION- Boehringer Ingelheim Animal Health Uk Ltd, "Mamyzin 269.5 mg/ml Powder and Solvent for Suspension for Injection for cattle", SUMMARY OF PRODUCT CHARACTERISTICS, (20181101), pages 1 - 5, XP093011784-
OPPOSITION- Buckwalter F.H., Dickison H.L., "The effect of vehicle and particle size on the absorption, by the intramuscular route, of procaine penicillin G suspensions", Journal of the American Pharmaceutical Association (Scientific ed.), (19580901), vol. 47, no. 9, pages 661 - 666, XP093011828-
OPPOSITION- Emea, "Penethamate (Extension to all mammalian species)", SUMMARY REPORT COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE, (20041201), pages 1 - 4, XP093011902-
OPPOSITION- "Ethyl Oleate", Rowe Raymond C., Sheskey Paul J., Quinn Marian E., Handbook of Pharmaceutical Excipients, 6th ed., (20090101), pages 259 - 260, XP093011921-
OPPOSITION- Florence Alexander T., An Introduction to Clinical Pharmaceutics, (20100101), pages 82 - 83, XP093011930-
OPPOSITION- "Ingel-Mamyzin", DIMDI, (19970620), Database accession no. 0180657, XP093011795-
OPPOSITION- Material safety data sheet (MSDS) for Excenelâ„¢ RTU-
OPPOSITION- "Medium-chain Triglycerides", Rowe Raymond C., Sheskey Paul J., Quinn Marian E., Handbook of Pharmaceutical Excipients, 6th ed., (20090101), pages 429 - 431, XP093011927-
OPPOSITION- New Zealand Government, "2011-2014 Antibiotic Sales Analysis", MPI Technical Paper No: 2016/65, (20161001), pages 1 - 29, XP093011778-
OPPOSITION- Pfizer, "Excenel® RTU", Product Data Sheet, (20060201), pages 1 - 2, XP093011906-
OPPOSITION- Pfizer, "Naxcel® brand of ceftiofur sodium sterile powdera", Product Data Sheet, (20060201), XP093011905-
OPPOSITION- Prescribing information for Excenelâ„¢ RTU-
OPPOSITION- Promotional material Naxcelâ„¢, Excenelâ„¢ and Excedeâ„¢-
OPPOSITION- Rawle A, "Basic principles of particle-size analysis", Surface Coatings International Part A, (20030101), vol. 2003/01, pages 1 - 8, XP055799816-
OPPOSITION- R.M. PATEL, "Parenteral suspension: an overview", International Journal of Current Pharmacuetical Research, (20100000), vol. 2, no. 3, pages 4 - 13, XP055031426-
OPPOSITION- "Sesame Oil", Rowe Raymond C., Sheskey Paul J., Quinn Marian E., Handbook of Pharmaceutical Excipients, 6th ed., (20090101), pages 614 - 615, XP093011924-
OPPOSITION- Summary of Product Characteristics Clamoxylâ„¢ RTU-
OPPOSITION- Summary of Product Characteristics for Cobactanâ„¢ 2.5%-
OPPOSITION- Summary of Product Characteristics for Mamyzinâ„¢-
OPPOSITION- Summary of Product Characteristics for Synuloxâ„¢ RTU-
OPPOSITION- Kenneth S. E. Su; John F. Quay; Kristina M. Campanale; John F. Stucky, "Nonaqueous cephalosporin suspension for parenteral administration: Cefazolin sodium", Journal of Pharmaceutical Sciences, American Chemical Society and American Pharmaceutical Association, US, (19841101), vol. 73, no. 11, doi:10.1002/jps.2600731129, ISSN 0022-3549, pages 1602 - 1606, XP009520834
OPPOSITION- Kenneth S. E. Su; John F. Quay; Kristina M. Campanale; John F. Stucky, "Nonaqueous cephalosporin suspension for parenteral administration: Cefazolin sodium", Journal of Pharmaceutical Sciences, US , (19841101), vol. 73, no. 11, doi:10.1002/jps.2600731129, ISSN 0022-3549, pages 1602 - 1606, XP009520834
OPPOSITION- Larsen Susan W; Thing Mette A; Larsen Claus, "Chapter 7 - Oily (Lipophilic) Solutions and Suspensions", Larsen Susan W; Thing Mette A; Larsen Claus, Wright et al., Long Acting Injections and Implants; Advances in Delivery Science and Technology, SPRINGER-VERLAG BERLIN, (20120101), pages 113 - 135, doi:10.1007/978-1-4614-0554-2_7, ISBN 978-1-4614-0553-5, XP009514630
OPPOSITION- Eremin V. A., Vakushin B. I., "Study of the possibility of replacing vegetable oils by ethyl oleate in the production of solutions for injection", Pharmaceutical Chemistry Journal, US , (19771001), vol. 11, no. 10, doi:10.1007/BF02627884, ISSN 0091-150X, pages 1413 - 1415, XP093011878
OPPOSITION- Enever, R.P. ; Lewis, G.A., "Long-acting contraceptive agents: The influence of pharmaceutical formulation upon biological activity of esters of norethisterone", STEROIDS, US , (19830301), vol. 41, no. 3, doi:10.1016/0039-128X(83)90108-3, ISSN 0039-128X, pages 369 - 380, XP023430091
OPPOSITION- JAIN et al., "A stability-indicating HPLC assay with diode array detection for a determination of a benzylpenicillin prodrug", Journal of pharmaceutical and biomedical analysis, (20090700), vol. 50, doi:10.1016/j.jpba.2009.06.046, pages 841 - 846, XP026640020
OPPOSITION- Jain, R. ; Wu, Z. ; Tucker, I.G., "A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions", Journal of Pharmaceutical and Biomedical Analysis, Elsevier B.V., AMSTERDAM, NL, (20091205), vol. 50, no. 5, doi:10.1016/j.jpba.2009.06.046, ISSN 0731-7085, pages 841 - 846, XP026640020
OPPOSITION- Fredholt Karin, Larsen Dorrit Høj, Larsen Claus, "Modification of in vitro drug release rate from oily parenteral depots using a formulation approach", European Journal of Pharmaceutical Sciences, NL , (20000901), vol. 11, no. 3, doi:10.1016/S0928-0987(00)00104-4, ISSN 0928-0987, pages 231 - 237, XP093011892
OPPOSITION- Hekman P., Nouws J.F.M., Van Ginneken C.A.M., "Effect of Tomanol® on the pharmacokinetics and tissue distribution of penicillin G in dairy cows", Veterinary Quarterly, (19820101), vol. 4, no. 1, doi:10.1080/01652176.1982.9693832, pages 12 - 18, XP093011813
OPPOSITION- Nouws J. F. M., Van Ginneken C. A. M., Hekman P., Ziv G., "Comparative plasma ampicillin levels and bioavailability of five parenteral ampicillin formulations in ruminant calves", VETERINARY QUARTERLY., KLUWER, NL, (19820401), vol. 4, no. 2, doi:10.1080/01652176.1982.9693841, ISSN 0165-2176, pages 62 - 71, XP055826108
OPPOSITION- Nouws J. F. M., Van Ginneken C. A. M., Hekman P., Ziv G., "Comparative plasma ampicillin levels and bioavailability of five parenteral ampicillin formulations in ruminant calves", VETERINARY QUARTERLY, NL , (19820401), vol. 4, no. 2, doi:10.1080/01652176.1982.9693841, ISSN 0165-2176, pages 62 - 71, XP055826108
OPPOSITION- LI M et al., "Interspecies mixed-effect pharmacokinetic modeling of penicillin G in cattle and swine", Antimicrobial Agents and Chemotherapy, (20140000), vol. 58, no. 8, pages 4495 - 4503, XP093011823
OTHER- "Lecithin", ROWE et al., Handbook of Pharmaceutical Excipients, (20090000), pages 385 - 387, XP055454882-
OTHER- MILLER, M. A.; ENGSTROM, J. D.; LUDHER, B. S.; JOHNSTON, K. P., "Low Viscosity Highly Concentrated Injectable Nonaqueous Suspensions of Lysozyme Microparticles /NIH Author Manuscript/", Langmuir / PMC, (20110217), pages 1 - 22, XP055400194-
OTHER- RheoSense, "Application Notes- Drug Injectability & Viscosity", (20160000), pages 1 - 5, URL: http://www.rheosense.com/applications/viscosity/drug-injectability, XP055400205-
OTHER- JAIN R. et al., "A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions", JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,, (20090000), vol. 50, no. 5, pages 841 - 846, XP026640020
OTHER- JAIN R. et al., "A stability-indicating HPLC assay with diode array detection for the determination of a benzylpenicillin prodrug in aqueous solutions", J Pharm Biomed Anal, (20090000), vol. 50, pages 841 - 846, XP026640020

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents